André Andonian, Flagship chair of Asia Pacific and senior advisor
November 7, 2023 05:00 PM ESTUpdated November 11, 01:48 AM
Financing
Startups
Bioregnum

Flag­ship Pi­o­neer­ing takes an­oth­er big step across the globe, plant­i­ng its biotech flag in Asia

Flag­ship Pi­o­neer­ing is stak­ing out a new home base in Asia, re­cruit­ing a long­time McK­in­sey vet — and a col­league to Flag­ship CEO Noubar Afeyan …

Endpoints Premium

This article is available only to Premium subscribers

Upgrade to Premium for unlimited access and Premium exclusives.

UPGRADE
TRENDING NOW

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

Nor­bert Bischof­berg­er's time as Kro­nos CEO ends as biotech seeks new life

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

Bris­tol My­ers sues the fed­er­al gov­ern­ment over 340B, fol­low­ing oth­er drug­mak­ers

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

A service from the Financial Times